 |
| Opinion |  Top |
|
 |
|
| Editorials |
|
|
|
Moving genomics from discovery to development p923
doi:10.1038/nbt1097-923a
PDF
(145K)
|
|
|
|
"Solutions" companies supply answers p923
doi:10.1038/nbt1097-923b
PDF
(145K)
|
|
 |
|
| Commentary |
|
|
|
Pharmacogenetics and drug metabolism pp925 - 926
Simon Ball
& Neil Borman
doi:10.1038/nbt1097-925
References | PDF
(401K)
|
|
|
|
| Correspondence |
|
|
|
Discoveries in complex biosystems p927
Carl Persson
doi:10.1038/nbt1097-927a
References | PDF
(156K)
|
|
|
|
Corrections p927
doi:10.1038/nbt1097-927b
PDF
(156K)
|
|
| In Brief | Top |
|
|
|
| Business and Regulatory News |
|
|
|
Business & Regulatory News pp929 - 931
doi:10.1038/nbt1097-929
PDF
(608K)
|
|
|
|
| Research News |
|
|
|
Research News p932
doi:10.1038/nbt1097-932
PDF
(262K)
|
|
|
|
| This Month in Biotechnology |
|
|
|
This Month in Nature Biotechnology p933
doi:10.1038/nbt1097-933
PDF
(280K)
|
|
| Analysis | Top |
|
|
|
| Business and Regulatory News |
|
|
|
Amylin's pramlintide best of bad bunch of diabetes drugs p935
Vicki Brower
doi:10.1038/nbt1097-935
PDF
(151K)
|
|
|
|
Wrangle over rights to BRCA1 p936
Ken Chahine
doi:10.1038/nbt1097-936
PDF
(213K)
|
|
|
|
Rosetta Inpharmatics chips in pp937 - 938
Vicki Glaser
doi:10.1038/nbt1097-937
PDF
(469K)
|
|
|
|
Netanyahu's $100 million fund pp938 - 939
Vicki Brower
doi:10.1038/nbt1097-938
PDF
(401K)
|
|
|
|
Environmental genome project planned p939
Chris Dickey
doi:10.1038/nbt1097-939
PDF
(208K)
|
|
|
|
Amgen's NESP heats up competition in lucrative erythropoietin market p940
Ingeborg Fürst
doi:10.1038/nbt1097-940
PDF
(194K)
|
|
|
|
EASDAQ grows slowly, but surely p941
Sylvia Davidson
doi:10.1038/nbt1097-941
PDF
(218K)
|
|
|
|
300 German biotechnology companies by 1998 p943
Ellen Perrenboom
doi:10.1038/nbt0997-943
PDF
(211K)
|
|
|
|
| Research News |
|
|
|
Transgenic factor VIII: The milky way and beyond pp945 - 946
Lothar Hennighausen
doi:10.1038/nbt1097-945
References | PDF
(381K)
|
|
|
|
An eye for an eye: New models of genetic ocular disease pp947 - 948
Kevin Gregory Evans
& Richard G. Weleber
doi:10.1038/nbt1097-947
References | PDF
(303K)
|
|
|
|
Lignin variants challenge wooden thinking pp948 - 949
Jim Kling
doi:10.1038/nbt1097-948
PDF
(333K)
|
|
|
|
Say cheese! The maturing science of starter cultures pp950 - 951
Gerald F. Fitzgerald
doi:10.1038/nbt1097-950
References | PDF
(333K)
|
|
|
|
lnterleukin-6: An antagonizing problem becomes a solution pp952 - 953
Matthew B. Rettig
doi:10.1038/nbt1097-952
References | PDF
(270K)
|
|
|
|
Turning poison eaters inside out p953
Simon Silver
& Amit Gupta
doi:10.1038/nbt1097-953
References | PDF
(150K)
|
|
| Features | Top |
|
|
|
Laying the foundations for personalized medicines pp954 - 957
Andrew Marshall
doi:10.1038/nbt1097-954
Abstract + references | PDF
(811K)
|
|
|
|
From bench to business: Career opportunities in biotechnology pp958 - 960
Mark D. Dibner
& Cynthia J. Sollod
doi:10.1038/nbt1097-958
Abstract + references | PDF
(461K)
|
|
| Research Review | Top |
|
|
|
Applications of the green fluorescent protein in cell biology and biotechnology pp961 - 964
Tom Misteli
& David L. Spector
doi:10.1038/nbt1097-961
Abstract + references | PDF
(545K)
|
|
| Research Articles | Top |
|
|
|
Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa pp965 - 970
Robert M. Petters, Curtis A. Alexander, Kevin D. Wells, E. Bruce Collins, Jeffrey R. Sommer, Maria R. Blanton, Guadalupe Rojas, Ying Hao, William L. Flowers, Eyal Banin, Artur V. Cideciyan, Samuel G. Jacobson
& Fulton Wong
doi:10.1038/nbt1097-965
Abstract + references | PDF
(1,070K)
|
|
|
|
Transgenic pigs produce functional human factor VIII in milk pp971 - 975
Rekha K. Paleyanda, William H. Velander, Timothy K. Lee, Dorothea H. Scandella, Francis C. Gwazdauskas, James W. Knight, Leon W. Hoyer, William N. Drohan
& Henryk Lubon
doi:10.1038/nbt1097-971
Abstract + references | PDF
(669K)
|
|
|
|
Food-grade controlled lysis of Lactococcus lactis for accelerated cheese ripening pp976 - 979
Pascalle G.G.A. de Ruyter, Oscar P. Kuipers, Wilco C. Meijer
& Willem M. de Vos
doi:10.1038/nbt1097-976
Abstract + references | PDF
(540K)
|
|
|
|
Design of thermolabile bacteriophage repressor mutants by comparative molecular modeling pp980 - 983
Arjen Nauta, Bertus van den Burg, Harma Karsens, Gerard Venema
& Jan Kok
doi:10.1038/nbt1097-980
Abstract + references | PDF
(622K)
|
|
|
|
Biodegradation of organophosphorus pesticides by surface-expressed organophosphorus hydrolase pp984 - 987
Richard D. Richins, Irina Kaneva, Ashok Mulchandani
& Wilfred Chen
doi:10.1038/nbt1097-984
Abstract + references | PDF
(512K)
|
|
|
|
Overexpression of glutathione S-transferase/glutathioneperoxidase enhances the growth of transgenic tobacco seedlings during stress pp988 - 991
Virginia P. Roxas, Roger K. Smith Jr., Eric R. Allen
& Randy D. Allen
doi:10.1038/nbt1097-988
Abstract + references | PDF
(528K)
|
|
|
|
Plant resistance to fungal infection induced by nontoxic pokeweed antiviral protein mutants pp992 - 996
Oleg Zoubenko, Fatih Uckun, Yoonkang Hur, IIan Chet
& Nilgun Tumer
doi:10.1038/nbt1097-992
Abstract + references | PDF
(673K)
|
|
|
|
Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist pp997 - 1001
Laura Ciapponi, Domenico Maione, Ariane Scoumanne, Patrizia Costa, Morten Bagge Hansen, Morten Svenson, Klaus Bendtzen, Tonino Alonzi, Giacomo Paonessa, Riccardo Cortese, Gennaro Ciliberto
& Rocco Savino
doi:10.1038/nbt1097-997
Abstract + references | PDF
(546K)
|
|
|
|
A two-component expression system that responds to inflammatory stimuli in vivo pp1002 - 1006
Alan W. Varley, Steven M. Geiszler, Richard B. Gaynor
& Robert S. Munford
doi:10.1038/nbt1097-1002
Abstract + references | PDF
(627K)
|
|
|
|
Human hematopoietic progenitor cell isolation based on galactose-specific cell surface binding pp1007 - 1011
George G. Pipia
& Michael W. Long
doi:10.1038/nbt1097-1007
Abstract + references | PDF
(654K)
|
|
| Resources | Top |
|
|
|
| Book Review |
|
|
|
Our genetic future? pp1013 - 1014
Ruth Schwartz Cowan
doi:10.1038/nbt1097-1013
Abstract | PDF
(291K)
|
|
|
|
Managing for the environment pp1014 - 1015
Sheldon Krimsky
doi:10.1038/nbt1097-1014
Abstract | PDF
(385K)
|
|
|
|
No stranger to controversy p1016
Harold Schmeck
doi:10.1038/nbt1097-1016
Abstract | PDF
(143K)
|
|
|
|
Product approval demystified p1017
George Morstyn
doi:10.1038/nbt1097-1017a
PDF
(156K)
|
|
|
|
Getting the chemistry right pp1017 - 1018
Paul Wentworth Jr.
doi:10.1038/nbt1097-1017b
PDF
(304K)
|
|
|
|
Drug design in the 1990s pp1018 - 1019
Philip M. Dean
doi:10.1038/nbt1097-1018
PDF
(305K)
|
|
|
|
Sweet medicine pp1019 - 1020
Christopher M. Starr
doi:10.1038/nbt1097-1019
PDF
(354K)
|
|
|
|
An old dog in search of new ticks pp1021 - 1022
Chaitan Khosla
doi:10.1038/nbt1097-1021
PDF
(375K)
|
|
|
|
A transgenic compendium engineered pp1022 - 1023
Henryk Lubon
doi:10.1038/nbt1097-1022
PDF
(321K)
|
|
|
|
| Patents |
|
|
|
Trading patent rights for research tools: What's at stake? pp1024 - 1026
Benjamin Thorner
doi:10.1038/nbt1097-1024
Abstract | PDF
(518K)
|
|
|
|
Patent applications in the area of expression systems p1027
doi:10.1038/nbt1097-1027
PDF
(292K)
|
|
|
|
| WWW Guide |
|
|
|
Biotechnology, development, and the Web p1028
Harvey Bialy
doi:10.1038/nbt1097-1028
PDF
(282K)
|
|
|
|
| People |
|
|
|
People p1029
doi:10.1038/nbt1097-1029
PDF
(199K)
|
|
|
|
| New Products |
|
|
|
Tips for your pipette pp1030 - 1032
Iku Lähteenmäki, John Hodgson
& Adam Michael
doi:10.1038/nbt1097-1030
Abstract | PDF
(603K)
|
|
|
|
Enzymes & reagents p1033
doi:10.1038/nbt1097-1033
PDF
(173K)
|
|
|
|
| Industry Trends |
|
|
|
Artificial intelligence for drug design pp1035 - 1036
Aris Persidis
& Andreas Persidis
doi:10.1038/nbt1097-1035
Abstract + references | PDF
(357K)
|
|
|
Top |
|
|
